Strides Arcolab receives ANDA approval from US FDA

Polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution will be manufactured at the company’s oral dosage facility at Bangalore

Strides Arcolab has received approval from the United States Food & Drug Administration (US FDA) for polyethylene glycol 3350, sodium chloride, sodium bicarbonate, and potassium chloride for oral solution, 420 grams/11.2 grams/5.72 grams/1.48 grams/4 litres.

According to IMS data, the US market for polyethylene glycol 3350, sodium chloride, sodium bicarbonate, and potassium chloride for oral solution is approximately $20. The product will be manufactured at the company’s oral dosage facility at Bangalore and marketed by Strides in the US Market.